RIGI and acute myeloid leukemia: A recent study has shown that foreign RNA-unliganded RIG-I inhibits the Src-facilitated activation of Akt-mammalian target of rapamycin (mTOR) in acute myeloid leukemia cells by competing with Src for recognition of Akt [5].